Hummingbird Bioscience
PrivateLast Round
Series C
May 18, 2021
Total Funding Raised
$182.1M
Company Overview
Hummingbird Bioscience is a biotechnology company that develops innovative therapeutic antibody-based drugs aimed at addressing the significant unmet needs of oncology and immuno-oncology patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hummingbird Bioscience Comparables
Compare Hummingbird Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbCellera Biologics Inc. | 81% | |
| Biolojic Design | 81% | |
| BenevolentAI | 79% |
Hummingbird Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2021 | ||||
| Series B Extension | May 10, 2020 | ||||
| Series B | Dec 4, 2019 | ||||
| Series A Extension | Jul 10, 2019 | ||||
| Grant | Feb 21, 2019 | ||||
Series A | May 3, 2017 |
Key People
Founding team and executive leadership
Hummingbird Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heritas Capital Management | Series B, Series C, Series B Extension, Series A Extension |
| Cancer Prevention & Research Institute of Texas | Grant |
| Frazier Healthcare Partners | Series C |
| SEEDS Capital | Series B, Series C, Series B Extension, Series A Extension |
| Mirae Asset | Series B, Series C |
| Octagon Capital Advisors | Series C |
| Ally Bridge Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2025
Clinical-stage monoclonal antibodies and antibody-drug conjugates in oncology and autoimmunity.
- May 18, 2021
$125M round led by Novo Holdings.
Recent news
Latest coverage and updates
- partners_withSep 28, 2026
Hummingbird Bioscience Pte Ltd. partners with LynxKite.
- is_developingSep 28, 2026
Hummingbird Bioscience Pte Ltd. is developing Toxicity Knowledge Graph.
- hiresSep 15, 2026
Hummingbird Bioscience Pte Ltd. hired James Garner as President on Sep 15th '26.
- hiresSep 15, 2026
Hummingbird Bioscience Pte Ltd. hired James Garner as President on Sep 15th '26.
- attends_eventJul 14, 2026
Hummingbird Bioscience Pte. Ltd. attended event AI Discovery Awards on Jul 14th '26.
Hummingbird Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hummingbird Bioscience's valuation, stock price, and market status.
Is Hummingbird Bioscience a public or private company?
Hummingbird Bioscience is a private company.
What is the current stock price of Hummingbird Bioscience?
Hummingbird Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Hummingbird Bioscience worth (valuation)?
Valuation information for Hummingbird Bioscience is not publicly available.
Can I buy Hummingbird Bioscience stock?
Hummingbird Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hummingbird Bioscience's last funding round?
Hummingbird Bioscience's most recent funding round was Series C on May 18, 2021.
Who are the main investors in Hummingbird Bioscience?
Key investors in Hummingbird Bioscience include Heritas Capital Management, SEEDS Capital, Mirae Asset, Mirae Asset Securities, Novo Holdings.
Will Hummingbird Bioscience IPO soon?
No public IPO plans have been announced for Hummingbird Bioscience.
How can I track Hummingbird Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hummingbird Bioscience's secondary market activity and sign up for updates.